Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Bone disease management and systemic treatment

From: Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity?

Therapeutic on first SRE n - %
Radiotherapy 38 - 70.4%
Surgery followed by radiotherapy 9 - 14.8%
Percutaneous vertebroplasty/Medical treatments 2/6 - 14.8%
Biphosphonates 33 - 60%
Systemic treatment  
First line chemotherapy 53 - 96%
Second line chemotherapy 31 - 56%